CIK 0000842023
- Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- Operating
- EIN
- 411427402
- Phone
- +1 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- 4 Grant or award Director acquired 391 shares (grant or award)
- 4 Grant or award Director acquired 391 shares (grant or award)
- 4 Grant or award Director acquired 391 shares (grant or award)
- 4 Grant or award Director acquired 391 shares (grant or award)
- 4 Shares withheld for taxes SVP - General Counsel gave up 849 shares (to pay taxes)
- 4 Shares withheld for taxes President-Protein Sciences gave up 856 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,184 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 12,287 shares (to pay taxes)
- 4 Grant or award Chief Executive Officer acquired 8,586 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 89 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP - General Counsel sold 9,079 shares at an average $275.76 ($2,503,652)
- 4 Open-market sale Chief Financial Officer sold 24,079 shares at an average $271.59 ($6,539,634)
- 4 Open-market sale Director sold 3,985 shares at $260.00 ($1,036,100)
- 4 Open-market sale SVP - General Counsel sold 5,995 shares at an average $260.14 ($1,559,533)
- 4 Open-market sale President-Protein Sciences sold 11,357 shares at an average $261.45 ($2,969,274)
Page 13 of 35 · 695 filings